Aveanna Reaffirms Full Year 2023 Guidance Of Revenue Of At Least $1.84B (Consensus $1.87B), Adjusted EBITDA Of At Least $130M
Portfolio Pulse from Benzinga Newsdesk
Aveanna Healthcare reaffirms its full-year 2023 guidance, expecting revenue of at least $1.84 billion and adjusted EBITDA of at least $130 million.
June 15, 2023 | 11:11 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Aveanna Healthcare (AVAH) reaffirms 2023 guidance with revenue of at least $1.84 billion and adjusted EBITDA of at least $130 million.
Aveanna Healthcare's reaffirmation of its 2023 guidance indicates that the company is confident in its financial performance. However, the consensus estimate is slightly higher at $1.87 billion in revenue. This news may not have a significant short-term impact on the stock price, as it is a reaffirmation rather than an update or change in guidance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100